Preliminary evidence of the efficacy of probiotic eye-drop treatment in patients with vernal keratoconjunctivitis

Alfonso Iovieno, Alessandro Lambiase, Marta Sacchetti, Barbara Stampachiacchiere, Alessandra Micera, Stefano Bonini

Research output: Contribution to journalArticle

Abstract

Background: Probiotics have been shown to improve allergic inflammation. The aim of this study was to evaluate the efficacy of Lactobacillus Acidophilus eye-drops in controlling signs and symptoms of vernal keratoconjunctivitis (VKC). Methods: Seven patients (mean age 11.8±4.3; five M, two F) with mild to moderate VKC were included in the study. Lactobacillus Acidophilus diluted in saline solution (2±108 CFU/ml) was administrated as eye-drops four times daily for 4 weeks in both eyes. Clinical signs (conjunctival hyperemia, chemosis, secretion, Trantas dots, superficial punctuate keratitis) and symptoms (itching, photophobia, burning, tearing) were evaluated and scored from 0 to 3 at baseline, after 2 and 4 weeks of treatment. Total sign (TSS) and symptom (TSyS) scores were calculated. Conjunctival impression cytology was performed in three patients at baseline and after 4 weeks of treatment, in order to evaluate the expression of ICAM-1 and TLR-4. Results: In the six out of seven patients who completed the study, symptoms were significantly improved after both 2 weeks (TSyS: baseline 6.7±0.9 vs 4.1±1.2; p=0.017) and 4 weeks (TSyS: baseline 6.7±0.9 vs 3.6±1.2, p=0.011) of treatment. A significant improvement of clinical signs was observed after 4 weeks of treatment (TSS: baseline 7.5±1.6 vs 3.9±1.7, p=0.034) but not after 2 weeks of treatment (TSS: baseline 7.5±1.6 vs 5.3±1.5; NS). In particular, photophobia was significantly reduced (2±0.6 vs 1±0.3; p=0.023) at 2 weeks, while at 4 weeks the scores for itching (1.8±0.3 vs 1±0.3), tearing (1.6±0.4 vs 0.8±0.2), conjunctival hyperemia (2.3±0.2 vs 1.4±0.5) and chemosis (1.2±0.4 vs 0.4±0.4) were significantly lower compared to baseline. A down-regulation of ICAM-1 and TLR-4 was observed in two patients showing clinical improvement after 4 weeks of treatment. Conclusion: Our open pilot study showed that 1-month treatment with probiotic eye-drops improves signs and symptoms in patients with VKC. Additional double-blind controlled clinical trials with a larger sample of patients are needed to confirm the effects of topical Lactobacilli on VKC patients.

Original languageEnglish
Pages (from-to)435-441
Number of pages7
JournalGraefe's Archive for Clinical and Experimental Ophthalmology
Volume246
Issue number3
DOIs
Publication statusPublished - Mar 2008

Fingerprint

Allergic Conjunctivitis
Ophthalmic Solutions
Probiotics
Signs and Symptoms
Lactobacillus acidophilus
Photophobia
Hyperemia
Intercellular Adhesion Molecule-1
Pruritus
Therapeutics
Keratitis
Controlled Clinical Trials
Lactobacillus
Sodium Chloride
Cell Biology
Down-Regulation
Inflammation

Keywords

  • Allergy
  • Conjunctiva
  • Lactobacillus Acidophilus
  • Probiotic
  • Vernal keratoconjunctivitis

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Preliminary evidence of the efficacy of probiotic eye-drop treatment in patients with vernal keratoconjunctivitis. / Iovieno, Alfonso; Lambiase, Alessandro; Sacchetti, Marta; Stampachiacchiere, Barbara; Micera, Alessandra; Bonini, Stefano.

In: Graefe's Archive for Clinical and Experimental Ophthalmology, Vol. 246, No. 3, 03.2008, p. 435-441.

Research output: Contribution to journalArticle

Iovieno, Alfonso ; Lambiase, Alessandro ; Sacchetti, Marta ; Stampachiacchiere, Barbara ; Micera, Alessandra ; Bonini, Stefano. / Preliminary evidence of the efficacy of probiotic eye-drop treatment in patients with vernal keratoconjunctivitis. In: Graefe's Archive for Clinical and Experimental Ophthalmology. 2008 ; Vol. 246, No. 3. pp. 435-441.
@article{54682d990de24d4ba86218f2d0a14504,
title = "Preliminary evidence of the efficacy of probiotic eye-drop treatment in patients with vernal keratoconjunctivitis",
abstract = "Background: Probiotics have been shown to improve allergic inflammation. The aim of this study was to evaluate the efficacy of Lactobacillus Acidophilus eye-drops in controlling signs and symptoms of vernal keratoconjunctivitis (VKC). Methods: Seven patients (mean age 11.8±4.3; five M, two F) with mild to moderate VKC were included in the study. Lactobacillus Acidophilus diluted in saline solution (2±108 CFU/ml) was administrated as eye-drops four times daily for 4 weeks in both eyes. Clinical signs (conjunctival hyperemia, chemosis, secretion, Trantas dots, superficial punctuate keratitis) and symptoms (itching, photophobia, burning, tearing) were evaluated and scored from 0 to 3 at baseline, after 2 and 4 weeks of treatment. Total sign (TSS) and symptom (TSyS) scores were calculated. Conjunctival impression cytology was performed in three patients at baseline and after 4 weeks of treatment, in order to evaluate the expression of ICAM-1 and TLR-4. Results: In the six out of seven patients who completed the study, symptoms were significantly improved after both 2 weeks (TSyS: baseline 6.7±0.9 vs 4.1±1.2; p=0.017) and 4 weeks (TSyS: baseline 6.7±0.9 vs 3.6±1.2, p=0.011) of treatment. A significant improvement of clinical signs was observed after 4 weeks of treatment (TSS: baseline 7.5±1.6 vs 3.9±1.7, p=0.034) but not after 2 weeks of treatment (TSS: baseline 7.5±1.6 vs 5.3±1.5; NS). In particular, photophobia was significantly reduced (2±0.6 vs 1±0.3; p=0.023) at 2 weeks, while at 4 weeks the scores for itching (1.8±0.3 vs 1±0.3), tearing (1.6±0.4 vs 0.8±0.2), conjunctival hyperemia (2.3±0.2 vs 1.4±0.5) and chemosis (1.2±0.4 vs 0.4±0.4) were significantly lower compared to baseline. A down-regulation of ICAM-1 and TLR-4 was observed in two patients showing clinical improvement after 4 weeks of treatment. Conclusion: Our open pilot study showed that 1-month treatment with probiotic eye-drops improves signs and symptoms in patients with VKC. Additional double-blind controlled clinical trials with a larger sample of patients are needed to confirm the effects of topical Lactobacilli on VKC patients.",
keywords = "Allergy, Conjunctiva, Lactobacillus Acidophilus, Probiotic, Vernal keratoconjunctivitis",
author = "Alfonso Iovieno and Alessandro Lambiase and Marta Sacchetti and Barbara Stampachiacchiere and Alessandra Micera and Stefano Bonini",
year = "2008",
month = "3",
doi = "10.1007/s00417-007-0682-6",
language = "English",
volume = "246",
pages = "435--441",
journal = "Graefe's Archive for Clinical and Experimental Ophthalmology",
issn = "0721-832X",
publisher = "Springer Verlag",
number = "3",

}

TY - JOUR

T1 - Preliminary evidence of the efficacy of probiotic eye-drop treatment in patients with vernal keratoconjunctivitis

AU - Iovieno, Alfonso

AU - Lambiase, Alessandro

AU - Sacchetti, Marta

AU - Stampachiacchiere, Barbara

AU - Micera, Alessandra

AU - Bonini, Stefano

PY - 2008/3

Y1 - 2008/3

N2 - Background: Probiotics have been shown to improve allergic inflammation. The aim of this study was to evaluate the efficacy of Lactobacillus Acidophilus eye-drops in controlling signs and symptoms of vernal keratoconjunctivitis (VKC). Methods: Seven patients (mean age 11.8±4.3; five M, two F) with mild to moderate VKC were included in the study. Lactobacillus Acidophilus diluted in saline solution (2±108 CFU/ml) was administrated as eye-drops four times daily for 4 weeks in both eyes. Clinical signs (conjunctival hyperemia, chemosis, secretion, Trantas dots, superficial punctuate keratitis) and symptoms (itching, photophobia, burning, tearing) were evaluated and scored from 0 to 3 at baseline, after 2 and 4 weeks of treatment. Total sign (TSS) and symptom (TSyS) scores were calculated. Conjunctival impression cytology was performed in three patients at baseline and after 4 weeks of treatment, in order to evaluate the expression of ICAM-1 and TLR-4. Results: In the six out of seven patients who completed the study, symptoms were significantly improved after both 2 weeks (TSyS: baseline 6.7±0.9 vs 4.1±1.2; p=0.017) and 4 weeks (TSyS: baseline 6.7±0.9 vs 3.6±1.2, p=0.011) of treatment. A significant improvement of clinical signs was observed after 4 weeks of treatment (TSS: baseline 7.5±1.6 vs 3.9±1.7, p=0.034) but not after 2 weeks of treatment (TSS: baseline 7.5±1.6 vs 5.3±1.5; NS). In particular, photophobia was significantly reduced (2±0.6 vs 1±0.3; p=0.023) at 2 weeks, while at 4 weeks the scores for itching (1.8±0.3 vs 1±0.3), tearing (1.6±0.4 vs 0.8±0.2), conjunctival hyperemia (2.3±0.2 vs 1.4±0.5) and chemosis (1.2±0.4 vs 0.4±0.4) were significantly lower compared to baseline. A down-regulation of ICAM-1 and TLR-4 was observed in two patients showing clinical improvement after 4 weeks of treatment. Conclusion: Our open pilot study showed that 1-month treatment with probiotic eye-drops improves signs and symptoms in patients with VKC. Additional double-blind controlled clinical trials with a larger sample of patients are needed to confirm the effects of topical Lactobacilli on VKC patients.

AB - Background: Probiotics have been shown to improve allergic inflammation. The aim of this study was to evaluate the efficacy of Lactobacillus Acidophilus eye-drops in controlling signs and symptoms of vernal keratoconjunctivitis (VKC). Methods: Seven patients (mean age 11.8±4.3; five M, two F) with mild to moderate VKC were included in the study. Lactobacillus Acidophilus diluted in saline solution (2±108 CFU/ml) was administrated as eye-drops four times daily for 4 weeks in both eyes. Clinical signs (conjunctival hyperemia, chemosis, secretion, Trantas dots, superficial punctuate keratitis) and symptoms (itching, photophobia, burning, tearing) were evaluated and scored from 0 to 3 at baseline, after 2 and 4 weeks of treatment. Total sign (TSS) and symptom (TSyS) scores were calculated. Conjunctival impression cytology was performed in three patients at baseline and after 4 weeks of treatment, in order to evaluate the expression of ICAM-1 and TLR-4. Results: In the six out of seven patients who completed the study, symptoms were significantly improved after both 2 weeks (TSyS: baseline 6.7±0.9 vs 4.1±1.2; p=0.017) and 4 weeks (TSyS: baseline 6.7±0.9 vs 3.6±1.2, p=0.011) of treatment. A significant improvement of clinical signs was observed after 4 weeks of treatment (TSS: baseline 7.5±1.6 vs 3.9±1.7, p=0.034) but not after 2 weeks of treatment (TSS: baseline 7.5±1.6 vs 5.3±1.5; NS). In particular, photophobia was significantly reduced (2±0.6 vs 1±0.3; p=0.023) at 2 weeks, while at 4 weeks the scores for itching (1.8±0.3 vs 1±0.3), tearing (1.6±0.4 vs 0.8±0.2), conjunctival hyperemia (2.3±0.2 vs 1.4±0.5) and chemosis (1.2±0.4 vs 0.4±0.4) were significantly lower compared to baseline. A down-regulation of ICAM-1 and TLR-4 was observed in two patients showing clinical improvement after 4 weeks of treatment. Conclusion: Our open pilot study showed that 1-month treatment with probiotic eye-drops improves signs and symptoms in patients with VKC. Additional double-blind controlled clinical trials with a larger sample of patients are needed to confirm the effects of topical Lactobacilli on VKC patients.

KW - Allergy

KW - Conjunctiva

KW - Lactobacillus Acidophilus

KW - Probiotic

KW - Vernal keratoconjunctivitis

UR - http://www.scopus.com/inward/record.url?scp=39049107852&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=39049107852&partnerID=8YFLogxK

U2 - 10.1007/s00417-007-0682-6

DO - 10.1007/s00417-007-0682-6

M3 - Article

C2 - 18040708

AN - SCOPUS:39049107852

VL - 246

SP - 435

EP - 441

JO - Graefe's Archive for Clinical and Experimental Ophthalmology

JF - Graefe's Archive for Clinical and Experimental Ophthalmology

SN - 0721-832X

IS - 3

ER -